University of Kansas Medical Center
Kansas City, Missouri, 66160, United States
NCT Number: NCT04996940
The study is a randomized crossover trial. Current menthol smokers will complete a session with each flavor of an electronic cigarette: menthol and tobacco. The objective of this survey is to assess for flavor preference.
Looking for future studies?
Notify Me21 year and older
All sexes
Interventional
Not applicable
Kansas City, Missouri, 66160, United States
Participants who report typically smoking menthol cigarettes will be invited to complete a session. Participants will undergo overnight tobacco/nicotine abstinence before the visit (eCO<12ppm). Participants will then be randomized 1:1 to e-cigarette flavor order (tobacco e-cigarette, menthol e-cigarette). They will complete a 30-minute ad libitum session with the first product, based on randomization, followed by a 1.5 hour standard washout period, followed by a 30-minute ad libitum vaping session with the second product. Throughout each session, puff topography will be measured via a pressure sensor attached to the e-cigarette device. Participants will complete self-report measures of smoking urges and withdrawal symptoms pre- and post-vaping session. In addition, they will complete measures of subjective vaping experience, perceptions of flavor, product demand, and intentions for future use.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will be randomized 1:1 to e-cigarette flavor order either:
Time frame: during the intervention
Using the questionnaire scale "Intentions for Future Use" How much each participant intends to use the products in the future.
Scale: "Think about the product you just used. If this was the only flavor available, how likely would you be to try this flavor again?
Time frame: during the intervention
Please indicate how you are feeling right now on a scale from 0 to 100 where 0 is not at all and 100 is extremely.
How pleasant would the e-cigarette be to use right now? The observed range of responses from participants for both arms was 0 to 100. Not all participants completed all study measures so the number of respondents is lower than enrolled.
Time frame: during the intervention
On a scale from 0 to 100 where 0 is not at all and 100 is extremely, to what extent did you like the flavor you just used? The observed range of responses from participants in both arms was from 0 to 100.
Not all participants completed all study measures so the number of respondents is lower than enrolled.
Time frame: during the intervention
On a scale from 0 to 100 where 0 is not at all and 100 is extremely, how willing would you be to use the flavor you just used again in the future? The observed range of responses from participants in both arms was from 0 to 100.
Not all participants completed all study measures so the number of respondents is lower than enrolled.
University of Kansas Medical Center
Other
Comparative Acceptability of Tobacco and Menthol Flavored E-cigarettes Among Menthol Cigarette Smokers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05110872
Behavior, Chemically-Induced Disorders
Roanoke, Virginia, United States
View Trial DetailsNCT04090879
Behavior, Chemically-Induced Disorders
Providence, Rhode Island, United States
View Trial DetailsNCT04092101
Behavior, Chemically-Induced Disorders
Baltimore, Maryland, United States
View Trial DetailsNCT04092387
Behavior, Chemically-Induced Disorders
Baltimore, Maryland, United States
View Trial Details